TD Cowen Maintains Buy on Natera, Raises Price Target to $480
10/13/2026
Impact: 85
Healthcare
TD Cowen analyst Dan Brennan has maintained a Buy rating on Natera (NASDAQ: NTRA) and increased the price target from $340 to $480. This adjustment reflects a positive outlook on the company's performance.
AI summary, not financial advice
Share: